retatrutide clinical trial results 2024 What Are the New Weight Loss Medications? Phase III retatrutide study demonstrates
Description
Diarrhea: 24% of participants Diarrhea usually appears as a transient symptom lasting one to three weeks rather than a persistent problem

Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials
The presence of GLP-1 receptors in testicular tissue and evidence of direct, weight-loss-independent effects on sperm function raises the possibility that GLP-1 drugs may act on male reproductive biology through two distinct mechanisms simultaneously: one systemic (through metabolic improvement) and one local (through direct testicular signaling)

Additionally, the anti-inflammatory effects of metformin and its role in reducing oxidative stress could attenuate the inflammatory response and fibrogenesis seen in cirrhosis [136]

Heart attacks, strokes, blood clots in the legs or lungs all become much more likely if youre obese, as do diabetes, dementia, kidney disease and a host of other life-limiting ailments

doi: 10.1111/j.1471-4159.2004.02914.x 53 TurtonMDOSheaDGunnIBeakSAEdwardsCMMeeranKet al
